1. Home
  2. SPCB vs RNXT Comparison

SPCB vs RNXT Comparison

Compare SPCB & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$8.90

Market Cap

43.8M

Sector

Technology

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.84

Market Cap

36.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
RNXT
Founded
1988
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
36.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SPCB
RNXT
Price
$8.90
$0.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$18.00
$7.75
AVG Volume (30 Days)
73.4K
214.1K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
$928,000.00
Revenue This Year
N/A
$2,795.35
Revenue Next Year
$27.13
$272.69
P/E Ratio
$10.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.14
$0.70
52 Week High
$18.95
$1.69

Technical Indicators

Market Signals
Indicator
SPCB
RNXT
Relative Strength Index (RSI) 43.64 40.98
Support Level $8.64 $0.92
Resistance Level $9.92 $1.00
Average True Range (ATR) 0.49 0.06
MACD 0.04 0.01
Stochastic Oscillator 28.62 17.21

Price Performance

Historical Comparison
SPCB
RNXT

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: